5th EASD Early Career Academy Journal Club - 1 Jun 2023 @EASDiabetes
5th EASD Early Career Academy Journal Club - 1 Jun 2023  @EASDiabetes
Uploaded June 2023 | Updated September 2026, 3 days ago
Dr. Arturo Roca-Rivada, first author of ‘Inhibition of the type 1 diabetes candidate gene PTPN2 aggravates tumor necrosis factor alpha-induced human beta cell dysfunction and death‘, which was recently published in Diabetologia, presented and discussed his research findings.
In addition, Dr. Roca-Rivada also shared some insight into his #career experiences.
#diabetes #t1d #tumor #betacell #research
5th EASD Early Career Academy Journal Club - 1 Jun 202311th ECA Webinar: SGLT2 inhibitors in type 1 diabetes#EASD2022 Interview with Stefan Bornstein on the issue of Long COVID and diabetes#EASD2022 Interview with Rury Holman and Amanda Adler on the UKPDS 44 Year Follow-upBest of EASD 2025 by the EASD Early Career Academy - featuring Dr. Lorenzo NestiEASD 2025: What if Insulin Resistance Could be Treated like Hypertension or High Cholesterol?EASD 2023 - EASD/ADA consensus report on hyperglycaemic crises in adult patients with diabetesEASD 2023 - Peter Thorn and Sushil Rane explaining the relationship between diabetes and the brainEASD 2025: Results from the SOUL Trial - The Cardiologists PerspectiveMeet the EASD Early Career Academy - Introducing Pierre Larraufie#EASD2022 Interview with the EASD-Lilly Centennial Anniversary Prize Lecturerer Matthias Tschöp9th ECA Webinar: How to DiRECT understanding of t2d into a major advance in clinical care
European Association for the Study of Diabetes |

5th EASD Early Career Academy Journal Club - 1 Jun 2023

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER